Juris Bundulis
Chief Executive Officer bei AS OLAINFARM
Profil
Juris Bundulis is currently the Chairman-Management Board at Olainfarm AS.
He is also a Member-Management Board at Grindeks fonds.
Zinatnes un izglitibas atbalstam AS and a Member-Supervisory Board at Pharma & Chemistry Competence Centre of Latvia Ltd.
Previously, he served as the Chairman-Management Board at Grindeks.
AS from 2012 to 2020.
He also worked as a Secretary at Latvia Ministry of Health.
Dr. Bundulis holds undergraduate and doctorate degrees from the University of Latvia.
Aktive Positionen von Juris Bundulis
Unternehmen | Position | Beginn |
---|---|---|
AS OLAINFARM | Chief Executive Officer | 19.06.2021 |
Grindeks fonds Zinatnes un izglitibas atbalstam AS | Corporate Officer/Principal | - |
Pharma & Chemistry Competence Centre of Latvia Ltd.
Pharma & Chemistry Competence Centre of Latvia Ltd. Miscellaneous Commercial ServicesCommercial Services Pharma & Chemistry Competence Centre of Latvia Ltd. is a private company based in Riga, Latvia. The Latvian company engages in research and experimental development on biotechnology. | Director/Board Member | - |
Ehemalige bekannte Positionen von Juris Bundulis
Unternehmen | Position | Ende |
---|---|---|
GRINDEKS | Chief Executive Officer | 21.01.2020 |
Latvia Ministry of Health | Corporate Secretary | - |
Ausbildung von Juris Bundulis
University of Latvia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Olainfarm AS
Olainfarm AS Pharmaceuticals: MajorHealth Technology Olainfarm AS engages in the manufacture and distribution of chemical and pharmaceutical products. It operates through the following segments: Medicine Production, Wholesale, Retail, Compression Materials, and Other. The Medicine Production segment focuses on the production and sales of finished form medicines and chemicals. The Wholesale segment comprises the sales of medicine and other products to retailers. The Retail segment involves the sales of the pharmacy chain of the group. The Compression Materials segment consists of the production and sale of elastic and compression materials. The Other segments includes the groups business lines. The company was founded in October 1972 and is headquartered in Olaine, Latvia. | Health Technology |
Grindeks AS
Grindeks AS Pharmaceuticals: MajorHealth Technology Grindeks AS produces pharmaceutical, medical, and phytochemical medicine. It engages in the research, development, manufacturing, and sales of original products, generics, and active pharmaceutical ingredients. The company specializes in the heart and cardiovascular, central nervous system, and anti-cancer medication therapeutic groups. Grindeks was founded in 1946 and is headquartered in Riga, Latvia. | Health Technology |
Latvia Ministry of Health | Government |
Grindeks fonds Zinatnes un izglitibas atbalstam AS | |
Pharma & Chemistry Competence Centre of Latvia Ltd.
Pharma & Chemistry Competence Centre of Latvia Ltd. Miscellaneous Commercial ServicesCommercial Services Pharma & Chemistry Competence Centre of Latvia Ltd. is a private company based in Riga, Latvia. The Latvian company engages in research and experimental development on biotechnology. | Commercial Services |